Hongwei Xu
-
- Pancreatitis Pathology and Treatment 5
- Gastrointestinal disorders and treatments 3
- Helicobacter pylori-related gastroenterology studies 3
-
- Intracerebral and Subarachnoid Hemorrhage Research 5
-
- Blood properties and coagulation 2
-
- Atherosclerosis and Cardiovascular Diseases 3
- Phagocytosis and Immune Regulation 3
-
- Single-cell and spatial transcriptomics 2
- Co-authors
- Peng FuZhongwei ZhangZhenzhen GaoXiaojun HeBin ChenXiaoping DuQidong YangZheng Zhang
- Cited by
- Cancer ResearchSurgeryNeurology
- Journals
- SHILAP Revista de lepidopterología (1 paper)PLoS ONE (1 paper)Chemical Engineering Journal (1 paper)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Hongwei Xu
31 papers receiving 242 citations
Peers
Comparison fields: 5 of 65
- Cancer Research 41
- Surgery 95
- Neurology 29
- Pulmonary and Respiratory Medicine 59
- Oncology 48
Countries citing papers authored by Hongwei Xu
This map shows the geographic impact of Hongwei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongwei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongwei Xu more than expected).
Fields of papers citing papers by Hongwei Xu
This network shows the impact of papers produced by Hongwei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongwei Xu. The network helps show where Hongwei Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hongwei Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 4 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 4 | |
| 8 | 2023 | 0 | |
| 9 | 2023 | 3 | |
| 10 | 2023 | 1 | |
| 11 | 2022 | 5 | |
| 12 | 2019 | 4 | |
| 13 | TMEM17 promotes malignant progression of breast cancer via AKT/GSK3β signaling | 2018 | 2 |
| 14 | 2018 | 18 | |
| 15 | 2014 | 6 | |
| 16 | 2014 | 17 | |
| 17 | 2013 | 18 | |
| 18 | 2012 | 12 | |
| 19 | 2012 | 2 | |
| 20 | Effect of sodium aescinate on Glutamate in cerebral hemorrhage | 2008 | 1 |
About Hongwei Xu
Hongwei Xu is a scholar working on Immunology, Surgery and Cancer Research, having authored 35 papers that have together received 245 indexed citations. Recurring topics across this work include Pancreatitis Pathology and Treatment (5 papers), Intracerebral and Subarachnoid Hemorrhage Research (5 papers), Gastrointestinal disorders and treatments (3 papers), Helicobacter pylori-related gastroenterology studies (3 papers), Atherosclerosis and Cardiovascular Diseases (3 papers), Phagocytosis and Immune Regulation (3 papers), Blood properties and coagulation (2 papers) and Single-cell and spatial transcriptomics (2 papers). The work is most often cited by research in Cancer Research (41 citations), Surgery (95 citations) and Neurology (29 citations). Hongwei Xu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Peng Fu, Zhongwei Zhang, Zhenzhen Gao, Xiaojun He, Bin Chen, Xiaoping Du, Qidong Yang, Zheng Zhang, Zhongwei Zhang and Xiaoqin Liu. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Chemical Engineering Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.